Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors
来自艾立布林脂质体制剂(E7389-LF)治疗日本晚期实体瘤患者的1期研究的剂量递增数据
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-21-3518.
Jun Sato,Toshio Shimizu,Takafumi Koyama,Satoru Iwasa,Akihiko Shimomura,Shunsuke Kondo,Shigehisa Kitano,Kan Yonemori,Yutaka Fujiwara,Kenji Tamura,Takuya Suzuki,Takao Takase,Reiko Nagai,Kohei Yamaguchi,Taro Semba,Zi-Ming Zhao,Min Ren,Noboru Yamamoto